Correlation Between China Construction and Eyebright Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Construction and Eyebright Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Construction and Eyebright Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Construction Bank and Eyebright Medical Technology, you can compare the effects of market volatilities on China Construction and Eyebright Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Construction with a short position of Eyebright Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Construction and Eyebright Medical.

Diversification Opportunities for China Construction and Eyebright Medical

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between China and Eyebright is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding China Construction Bank and Eyebright Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyebright Medical and China Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Construction Bank are associated (or correlated) with Eyebright Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyebright Medical has no effect on the direction of China Construction i.e., China Construction and Eyebright Medical go up and down completely randomly.

Pair Corralation between China Construction and Eyebright Medical

Assuming the 90 days trading horizon China Construction Bank is expected to generate 0.41 times more return on investment than Eyebright Medical. However, China Construction Bank is 2.44 times less risky than Eyebright Medical. It trades about 0.07 of its potential returns per unit of risk. Eyebright Medical Technology is currently generating about -0.06 per unit of risk. If you would invest  801.00  in China Construction Bank on October 6, 2024 and sell it today you would earn a total of  46.00  from holding China Construction Bank or generate 5.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

China Construction Bank  vs.  Eyebright Medical Technology

 Performance 
       Timeline  
China Construction Bank 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in China Construction Bank are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, China Construction is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Eyebright Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyebright Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

China Construction and Eyebright Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Construction and Eyebright Medical

The main advantage of trading using opposite China Construction and Eyebright Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Construction position performs unexpectedly, Eyebright Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyebright Medical will offset losses from the drop in Eyebright Medical's long position.
The idea behind China Construction Bank and Eyebright Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data